Pharmacokinetics and brain uptake of AM-36, a novel neuroprotective agent, following intravenous administration to rats

Autor: Joseph A. Nicolazzo, Jessica Anne Steuten, Tien Thuy Nguyen, Jennifer K. Callaway, Susan A. Charman, Bevyn Jarrott, Gregg D Smith, Kasiram Katneni
Rok vydání: 2008
Předmět:
Zdroj: Journal of Pharmacy and Pharmacology. 60:171-178
ISSN: 2042-7158
0022-3573
DOI: 10.1211/jpp.60.2.0005
Popis: The plasma pharmacokinetics and brain uptake of the novel neuroprotective agent AM-36 (1-(2-(4-chlorophenyl)-2-hydroxy)ethyl-4-(3,5-bis-(1, 1dimethylethyl)-4-hydroxyphenyl) methylpiperazine) were assessed over 72 h following i.v. administration to male Sprague-Dawley rats. At nominal i.v. doses of 0.2, 1 and 3 mg kg−1, AM-36 exhibited an extremely large volume of distribution (18.2–24.6 L kg−1) and a long terminal elimination half-life, ranging from 25.2 to 37.7 h. Over this dose range, AM-36 exhibited linear pharmacokinetics, with no apparent change in clearance, volume of distribution or dose-normalised area under the plasma concentration-time curve. AM-36 was very highly bound to plasma proteins (> 99.6%); however, this did not appear to affect the ability of AM-36 to permeate the blood-brain barrier. Following a single i.v. dose of AM-36 at 3 mg kg−1 to rats, brain concentrations were detected for up to 72 h, and the brain-to-plasma ratios were high at all time points (ranging from 8.2 at 5 min post-dose to 0.9 at 72 h post-dose). The very high brain uptake of AM-36 supports previous in-vivo efficacy studies demonstrating the neuroprotective effects of this compound when administered to rats with middle cerebral artery occlusion.
Databáze: OpenAIRE
Externí odkaz: